CAR-TCR Summit - Changing Lives with CAR-T And TCR Cell Immunotherapies
September 4 - 7, 2018 - Boston MA USHanson Wade
info@hansonwade.com
Phone:16174554188
Through industry defining, passionate and comprehensive content, the CAR-TCR Summit is dedicated to achieving two main goals: - Accelerate the discovery, translation and clinical development of more effective and potent CAR-T And TCR therapies for solid tumor indications, exploring innovative technology solutions to overcome genetic engineering, safety, tumor microenvironment and manufacturing scalability challenges. - Whether pursuing allogeneic or autologous approaches, ensure the accessibility, affordability and logistical delivery of current CAR-T cell therapies to patients in need around the world, defining best practice to overcome regulatory, pricing and reimbursement hurdles. With two CD19 approved drugs and the space getting increasingly crowded, this year's CAR-TCR Summit will leverage the experience from those leaders first to market, whilst unveiling the next generation technologies and breakthroughs being developed to enhance CAR-TCR efficacy in solid tumor indications. From discovery through to post-market commercialization, meet over 700 experts from across 35 countries during this 4-day end-to-end bonanza that brings you all you need to know from those you need to know it from. Not only will senior executives from the leading companies like Novartis, Kite and Juno be joining the conversation but this year we have 34 brand new speakers gracing our stages to discuss with you their novel strategies and pipelines, the key challenges they're facing and the solutions to overcome these. Become part of a dedicated community striving to deliver "curative" CAR-T And TCR cell therapies to patients in need.